Editor's Note: Press Release Outside Functional Foods Scope
Functional News covers ingredients, formulations, clinical nutrition, and dietary supplements — not implantable medical…
Functional News covers ingredients, formulations, clinical nutrition, and dietary supplements — not implantable medical…
With Farm Bill negotiations accelerating, hemp operators face a narrow lobbying window that could redefine THC threshol…
Revumenib is an FDA-approved menin inhibitor for acute leukemia, not a dietary ingredient, functional food, or nutraceu…
Cartilage regeneration biomarkers add mechanistic weight to the joint-health claim, positioning the ingredient for stru…
Initial data presented at EHA 2026 suggest tolerability in relapsed/refractory AML and HR-MDS patients, including those…
Functional News covers ingredients, clinical evidence, formulation, and regulation in the functional foods and nutraceu…
The oversubscribed round signals continued investor appetite for vertically integrated, U.S.-based biologics infrastruc…
Portfolio now exceeds 100 active granted patents and applications globally, reinforcing IP barriers in the competitive …
Quetzal Therapeutics' oral delivery format targets a key bioavailability challenge for a proven IV-administered oncolog…
The late-stage biopharmaceutical's shareholder vote arrives amid growing industry interest in bradykinin-pathway modula…
The partnership signals growing biotech interest in modifier-gene pathways, with potential downstream implications for …
The research-grade launch signals growing supplier investment in documentation standards as peptide ingredient scrutiny…